share_log

Avalon Holdings | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Avalon Holdings | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Avalon控股 | SC 13D/A:超过5%持股股东披露文件(修正)
美股SEC公告 ·  2024/08/16 06:03

Moomoo AI 已提取核心信息

On August 16th, 2024, Dr. Anil Choudary Nalluri, a psychiatrist based in Ohio, filed an amendment to the Schedule 13D with the United States Securities and Exchange Commission, disclosing his beneficial ownership of over 20% of Avalon Holdings Corporation's Class A Common Stock. Dr. Nalluri now owns 1,092,356 shares, representing approximately 33.226% of the company's outstanding shares. The filing indicates that these shares were acquired using personal funds and that Dr. Nalluri has sole voting and dispositive power over these shares. While Dr. Nalluri has not outlined any specific plans or proposals for the company, he reserves the right to change his investment strategy, which may include buying more shares, selling his stake, or formulating plans regarding the company's securities. The filing emphasizes that Dr. Nalluri's actions will be aimed at maximizing the value of his investments, taking into account market conditions and the business prospects of Avalon Holdings.
On August 16th, 2024, Dr. Anil Choudary Nalluri, a psychiatrist based in Ohio, filed an amendment to the Schedule 13D with the United States Securities and Exchange Commission, disclosing his beneficial ownership of over 20% of Avalon Holdings Corporation's Class A Common Stock. Dr. Nalluri now owns 1,092,356 shares, representing approximately 33.226% of the company's outstanding shares. The filing indicates that these shares were acquired using personal funds and that Dr. Nalluri has sole voting and dispositive power over these shares. While Dr. Nalluri has not outlined any specific plans or proposals for the company, he reserves the right to change his investment strategy, which may include buying more shares, selling his stake, or formulating plans regarding the company's securities. The filing emphasizes that Dr. Nalluri's actions will be aimed at maximizing the value of his investments, taking into account market conditions and the business prospects of Avalon Holdings.
2024年8月16日,俄亥俄州的精神病学家Anil Choudary Nalluri博士向美国证券交易委员会提交修正案的13D表,公开披露了他对Avalon控股股份有限公司A类普通股20%以上的受益所有权。Nalluri博士现在拥有1,092,356股股份,约占公司已发行股份的33.226%。文件显示,这些股份是用个人资金购得的,Nalluri博士对这些股份拥有唯一的投票和处理权。虽然Nalluri博士尚未概述该公司的任何具体计划或建议,但他保留改变他的投资策略的权利,这可能包括购买更多股票、出售他的股份或制定有关该公司证券的计划。文件强调,Nalluri博士的行动将旨在充分考虑市场条件和Avalon控股的业务前景,以最大限度地增加他的投资价值。
2024年8月16日,俄亥俄州的精神病学家Anil Choudary Nalluri博士向美国证券交易委员会提交修正案的13D表,公开披露了他对Avalon控股股份有限公司A类普通股20%以上的受益所有权。Nalluri博士现在拥有1,092,356股股份,约占公司已发行股份的33.226%。文件显示,这些股份是用个人资金购得的,Nalluri博士对这些股份拥有唯一的投票和处理权。虽然Nalluri博士尚未概述该公司的任何具体计划或建议,但他保留改变他的投资策略的权利,这可能包括购买更多股票、出售他的股份或制定有关该公司证券的计划。文件强调,Nalluri博士的行动将旨在充分考虑市场条件和Avalon控股的业务前景,以最大限度地增加他的投资价值。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息